When tested for its ability to rescue MR-induced resistance to anti-PD-1 immunotherapy (Extended Data Fig. 7a), GYY4137 sensitized subcutaneously grafted CT26.CL25 tumours in Balb/c mice fed with the MR diet to the anti-PD-1 treatment (Fig. 6a). Here, PDCD1 is linked to neoplasm.